Illumina, Inc.
ILMN
株式のランク
#618
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
株価
$262.32
最終同期: 2026-10-16
時価総額
$39.61B
変化（1日）
-2.09%
変化（1年）
174.80%
国
US
取引 Illumina, Inc. (ILMN)
カテゴリー
Healthcare
Illumina, Inc.（ILMN）の営業利益率
October 2026 時点の営業利益率 TTM: 20.97%
Illumina, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 20.97% です。2024 年末時点では -19.05% でした。
Illumina, Inc. の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 20.97% | 5.27% |
| 2025 | 19.92% | -204.57% |
| 2024 | -19.05% | -19.72% |
| 2023 | -23.73% | 772.43% |
| 2022 | -2.72% | -115.19% |
| 2021 | 17.91% | -35.58% |
| 2019 | 27.80% | 4.95% |
| 2018 | 26.49% | 20.30% |
| 2017 | 22.02% | -20.28% |
| 2016 | 27.62% | -0.11% |
| 2014 | 27.65% | 192.90% |
| 2013 | 9.44% | -46.00% |
| 2012 | 17.48% | -25.46% |
| 2011 | 23.45% | 24.40% |
| 2010 | 18.85% | 34.26% |
| 2008 | 14.04% | -117.10% |
| 2007 | -82.12% | -500.98% |
| 2006 | 20.48% | -287.89% |
| 2005 | -10.90% | -88.52% |
| 2003 | -94.96% | -77.22% |
| 2002 | -416.88% | -65.82% |
| 2001 | -1,219.59% | -31.29% |
| 2000 | -1,774.87% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.97% | -99.14% |
US
|
|
| 20.42% | -99.03% |
US
|
|
| -10.70% | -100.51% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.94% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。